Search Results - "Mulligan, S"

Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor‐KappaB Signaling by Anderson, Johnathon D., Johansson, Henrik J., Graham, Calvin S., Vesterlund, Mattias, Pham, Missy T., Bramlett, Charles S., Montgomery, Elizabeth N., Mellema, Matt S., Bardini, Renee L., Contreras, Zelenia, Hoon, Madeline, Bauer, Gerhard, Fink, Kyle D., Fury, Brian, Hendrix, Kyle J., Chedin, Frederic, EL‐Andaloussi, Samir, Hwang, Billie, Mulligan, Michael S., Lehtiö, Janne, Nolta, Jan A.

“…Mesenchymal stem cells (MSC) are known to facilitate healing of ischemic tissue related diseases through proangiogenic secretory proteins. Recent studies…”
Get full text

A Majority of Anterior Cruciate Ligament Injuries Can Be Prevented by Injury Prevention Programs: A Systematic Review of Randomized Controlled Trials and Cluster–Randomized Controlled Trials With Meta-analysis by Huang, Yu-Lun, Jung, Jaehun, Mulligan, Colin M.S., Oh, Jaekeun, Norcross, Marc F.

“…Background: Anterior cruciate ligament (ACL) injury prevention programs (IPPs) are generally accepted as being valuable for reducing injury risk. However,…”
Get full text

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer by Berfield, Kathleen S., Farjah, Farhood, Mulligan, Michael S.

“…The use of video-assisted thoracoscopic surgery (VATS) lobectomy has become a mainstay of modern-day thoracic oncology practice and the technique of choice for…”
Get full text

Cell of Origin Influences Pancreatic Cancer Subtype by Flowers, Brittany M, Xu, Hang, Mulligan, Abigail S, Hanson, Kathryn J, Seoane, Jose A, Vogel, Hannes, Curtis, Christina, Wood, Laura D, Attardi, Laura D

“…Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a 5-year survival rate of approximately 9%. An improved understanding of PDAC initiation and…”
Get more information

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL by Brown, J R, Hillmen, P, O’Brien, S, Barrientos, J C, Reddy, N M, Coutre, S E, Tam, C S, Mulligan, S P, Jaeger, U, Barr, P M, Furman, R R, Kipps, T J, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, M, DeVos, S, Moreno, C, Pagel, J M, Munir, T, Burger, J A, Chung, D, Lin, J, Gau, L, Chang, B, Cole, G, Hsu, E, James, D F, Byrd, J C

“…In the phase 3 RESONATE study, ibrutinib demonstrated superior progression-free survival (PFS), overall survival (OS) and overall response rate (ORR) compared…”
Get full text

Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling by Altman, Matthew C, Lai, Ying, Nolin, James D, Long, Sydney, Chen, Chien-Chang, Piliponsky, Adrian M, Altemeier, William A, Larmore, Megan, Frevert, Charles W, Mulligan, Michael S, Ziegler, Steven F, Debley, Jason S, Peters, Michael C, Hallstrand, Teal S

“…Asthma is a heterogeneous syndrome that has been subdivided into physiologic phenotypes and molecular endotypes. The most specific phenotypic manifestation of…”
Get full text

mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay by Anderson, Jennifer L, Mulligan, Timothy S, Shen, Meng-Chieh, Wang, Hui, Scahill, Catherine M, Tan, Frederick J, Du, Shao J, Busch-Nentwich, Elisabeth M, Farber, Steven A

“…As model organism-based research shifts from forward to reverse genetics approaches, largely due to the ease of genome editing technology, a low frequency of…”
Get full text

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation by Gelman, Andrew E., Fisher, Andrew J., Huang, Howard J., Baz, Maher A., Shaver, Ciara M., Egan, Thomas M., Mulligan, Micheal S.

Get full text

Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations by Carney, Randy P, Hazari, Sidhartha, Colquhoun, Macalistair, Tran, Di, Hwang, Billanna, Mulligan, Michael S, Bryers, James D, Girda, Eugenia, Leiserowitz, Gary S, Smith, Zachary J, Lam, Kit S

“…Extracellular vesicles (EVs), including exosomes, are circulating nanoscale particles heavily implicated in cell signaling and can be isolated in vast numbers…”
Get full text

Development of the larval lymphatic system in zebrafish by Jung, Hyun Min, Castranova, Daniel, Swift, Matthew R, Pham, Van N, Venero Galanternik, Marina, Isogai, Sumio, Butler, Matthew G, Mulligan, Timothy S, Weinstein, Brant M

“…The lymphatic vascular system is a hierarchically organized complex network essential for tissue fluid homeostasis, immune trafficking and absorption of…”
Get full text

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study by Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P

“…In chronic lymphocytic leukemia (CLL) the level of minimal residual disease (MRD) after therapy is an independent predictor of outcome. Given the increasing…”
Get full text

Epigenetic Changes Associated with Early Life Experiences: Saliva, A Biospecimen for DNA Methylation Signatures by Bearer, Elaine L, Mulligan, Brianna S

“…Background: Adverse Childhood Experiences (ACEs), which include traumatic injury, are associated with poor health outcomes in later life, yet the biological…”
Get full text

Role of Toll-Like Receptor-4 in Lung Ischemia-Reperfusion Injury by Merry, Heather E., MD, Phelan, Patrick, MD, Doak, Mathew R., BS, Zhao, Minqing, MD, PhD, Hwang, Billanna, MPH, Mulligan, Michael S., MD

“…Background Toll-like receptor-4 has been implicated in modulating ischemia-reperfusion injury in cardiac, hepatic, renal, and cerebral models. However, its…”
Get full text

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease by Fodero-Tavoletti, Michelle T, Okamura, Nobuyuki, Furumoto, Shozo, Mulligan, Rachel S, Connor, Andrea R, McLean, Catriona A, Cao, Diana, Rigopoulos, Angela, Cartwright, Glenn A, O'Keefe, Graeme, Gong, Sylvia, Adlard, Paul A, Barnham, Kevin J, Rowe, Christopher C, Masters, Colin L, Kudo, Yukitsuka, Cappai, Roberto, Yanai, Kazuhiko, Villemagne, Victor L

“…While considerable effort has focused on developing positron emission tomography β-amyloid imaging radiotracers for the early diagnosis of Alzheimer's disease,…”
Get full text

Ninety-Day Costs of Video-Assisted Thoracic Surgery Versus Open Lobectomy for Lung Cancer by Farjah, Farhood, MD, MPH, Backhus, Leah M., MD, Varghese, Thomas K., MD, MS, Mulligan, Michael S., MD, M. Cheng, Aaron, MD, Alfonso-Cristancho, Rafael, MD, PhD, Flum, David R., MD, MPH, Wood, Douglas E., MD

“…Background Complications after pulmonary resection lead to higher costs of care. Video-assisted thoracoscopic surgery (VATS) for lobectomy is associated with…”
Get full text

Histologic differentiation of severely dysplastic naevus from melanoma in situ: a departmental experience by Roche, D., McKenna, D., Tuthill, E., McCafferty, B., Mulligan, S., Hartel, P.

Get full text

Deceleration Profiles Between the Penultimate and Final Steps of Planned and Reactive Side-Step Cutting by Mulligan, Colin M S, Johnson, Samuel T, Pollard, Christine D, Hannigan, Kim S, Athanasiadis, Dimitrios, Norcross, Marc F

“…Noncontact anterior cruciate ligament injury often occurs during rapid deceleration and change-of-direction maneuvers. These activities require an athlete to…”
Get more information

Differential toll-like receptor activation in lung ischemia reperfusion injury by Phelan, Patrick, MD, Merry, Heather E., MD, Hwang, Billanna, MPH, Mulligan, Michael S., MD

“…Abstract Objective The requirement for toll-like receptors (TLRs) in lung ischemia reperfusion injury (LIRI) has been demonstrated but not fully characterized…”
Get full text

Pretreatment with bone marrow–derived mesenchymal stromal cell–conditioned media confers pulmonary ischemic tolerance by Hwang, Billanna, MPH, Liles, W. Conrad, MD, PhD, Waworuntu, Rachel, BS, Mulligan, Michael S., MD

“…Abstract Objective Mesenchymal stromal cell–based therapies have demonstrated efficacy in treating a variety of diseases. Despite the potential benefits, there…”
Get full text

A Nationwide Rise in the Use of Stents for Benign Esophageal Perforation by Thornblade, Lucas W., MD, Cheng, Aaron M., MD, Wood, Douglas E., MD, Mulligan, Michael S., MD, Saunders, Michael D., MD, He, Hao, PhD, Oelschlager, Brant K., MD, Flum, David R., MD, MPH, Farjah, Farhood, MD, MPH

“…Background Surgical repair or drainage is the standard treatment for benign esophageal perforation. The United States Food and Drug Administration has approved…”
Get full text